Nouveautés concernant l’asthme en médecine de premier recours [What's new on asthma in primary care]
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_14908144FEA7
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Nouveautés concernant l’asthme en médecine de premier recours [What's new on asthma in primary care]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
13/11/2019
Peer-reviewed
Oui
Volume
15
Number
671
Pages
2074-2079
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Abstract
The international recommendations of the management of asthma have been modified last years. Several therapies used since long time have no place in the management of moderate asthma today. The use of targeted immunotherapies against phenotypes of asthma are used more and more. Inhalant therapies are becoming more targeted towards the patient's wishes. This article specifies the novelties in management of asthma for de general practitioner, including the use of short acting beta2-agonists, which are no longer to be used without inhaled corticosteroid.
Keywords
Administration, Inhalation, Adrenal Cortex Hormones/administration & dosage, Adrenal Cortex Hormones/therapeutic use, Adrenergic beta-Agonists/administration & dosage, Adrenergic beta-Agonists/therapeutic use, Asthma/drug therapy, Asthma/therapy, Humans, Immunotherapy, Primary Health Care
Pubmed
Create date
20/11/2019 23:53
Last modification date
13/04/2024 7:08
Usage data
